Login

Jon Pilcher, CEO, Neuren Pharmaceuticals Ltd 00:00:00

Share On Facebook Share On Twitter

Neuren Pharmaceuticals hails FDA approval for trofinetide

Recent Videos

00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
00:10:00
James Anderson: Guanajuato Silver Expands with $50M Bolanitos Deal, Building Mexico’s Fastest-Growing Silver Producer|James Anderson,CHAIRMAN & CEO,Guanajuato Silver Company Ltd
00:10:00
Highland Copper Company Targets 2026 Construction Decision as Fully Permitted Copperwood Project Gains U.S. Federal Financing Momentum|Barry O’Shea,CEO,Highland Copper

Suggestions

00:10:00
Mastering Arbitrage Funds: Insights and Strategies for Smarter Investing | Bhavesh Jain - Co-Head, Factor Investing, Edelweiss Mutual Fund
00:10:00
We've built a team unified by one common goal|Will Robbins,partner,Contrary Capital
00:10:00
Stefan Meister, Executive Chairman of Partners Group, Discusses the Role of Private Markets in a Recalibrating Economy
00:10:00
Siriphong Aunthornphan and AIT's move into the AEC market|CEO , Advanced Information Technology Public Company Limited
00:10:00
Narciso Berberana, CEO of Aguas Andinas, leads strategic initiatives in water management and infrastructure development.
00:10:00
Industry Titan Unveils $1 Billion Play to Revolutionize Market with Silverstone Spin-Off and Future Acquisition Strategy|Brad Jacobs, Executive Chairman,XPO Logistics
00:10:00
We are devoted to our clients and it's reflected by our tenure, scale, and recognition as the industry's fastest growing target date suite. Our dedication to clients is matched by our commitment to our community. flexPATH Strategies is pleased to fundrais
00:10:00
Simplifying Wealth: Key Investment Insights with Michael Johnston
00:10:00
A global interactive entertainment venture capital firm focused on early stage investments|Michael Cheung,Founding General Partner,Makers Fund
00:10:00
Excelsior Gold: Advancing Kalgoorlie-Based Gold Project with Strong Potential
00:10:00
invest in companies where AI is a core component|Fang Yuan,General Partner,AIX Ventures
00:10:00
A mission-driven investment firm seeking to create outstanding|Pete Oberle,Managing Partner,Trailhead Capital

© 2017 - Neuhu+